[{"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0489-2018", "product_description": "Estradiol Hemihydrate USP (Micronized) (Soy) for prescription compounding, packaged in a) 5g (NDC 58597-8001-3); b) 25g (NDC 58597-8001-5);  c)100 g (NDC 58597-8001-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "4910 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot: #:a) 083017-1, Exp. 7/22/2022; b) 083017-1, Exp. 7/22/2022; c) 083017-1, Exp. 7/22/2022."}, {"status": "Terminated", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78991", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "N/A", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed U.S.A. nationwide.", "recall_number": "D-0324-2018", "product_description": "Relumins Advanced Glutathione kits, 900 mg vials, 1500 mg vials and 3000 mg vials", "product_quantity": "N/A", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act.", "recall_initiation_date": "20180119", "center_classification_date": "20180205", "termination_date": "20180913", "report_date": "20180214", "code_info": "all lots"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81457", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0262-2019", "product_description": "Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, 100-count bottoles, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141 Manufactured by: Sandoz Inc. Princeton, NJ 08540,NDC 16714-439-01", "product_quantity": "23053 bottles", "reason_for_recall": "Cross Contamination with Other Products", "recall_initiation_date": "20181102", "center_classification_date": "20181120", "termination_date": "20201002", "report_date": "20181121", "code_info": "Lot #: JA7319, JA 7320, JA7321, Exp.  03/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0168-2018", "product_description": "Bi-Est (Estriol/Estradiol) (80/20) + Progesterone 7.5 mg/200 mg Cream packaged in jars, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd Boca Raton, FL 33487.", "product_quantity": "300 jars", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 08172017@39 BUD: 12/15/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80365", "recalling_firm": "World Organix, LLC", "address_1": "6149 S. Rainbow Blvd #5", "address_2": "N/A", "postal_code": "89118", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1122-2018", "product_description": "Blissful Remedies Red Maeng Da, 100% Mitragyna Speciosa capsule, 50-count packaged White Foil Pouche, Dist. by World Organix LLC, Las Vegas, Nevada UPC#7 22589 32355 3", "product_quantity": "789  50-count pouches, total of 39,450 capsules", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: The firm is initiating a recall of some of its products due to the potential of high microbial loads.", "recall_initiation_date": "20180626", "center_classification_date": "20180823", "termination_date": "20240930", "report_date": "20180815", "code_info": "Lot Code: 102710. Best by date: 03/2019"}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: 20180124@10, BUD 04/05/2018; 20180220@9, BUD 05/21/2018; 20180102@33, BUD 04/02/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Lipoic Acid 25mg/mL, 5 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0640-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0788-2018", "product_description": "Sutent 50 mg capsules x28 NDC 00069-0550-38 42 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0273-2018", "product_description": "Medline Dressing Change Tray Kit, Sterile, Single use only. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "280 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDC2282; Lots: 16CB5897; 16PB9981", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077095"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-008", "65862-009", "65862-010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["861004", "861007", "861010"], "spl_id": ["c535450c-12fd-478d-ad45-743c5badfc28"], "spl_set_id": ["4ac6d01a-af26-44e7-ae2e-3618de0080aa"], "package_ndc": ["65862-008-50", "65862-008-60", "65862-008-90", "65862-008-01", "65862-008-33", "65862-008-05", "65862-008-99", "65862-008-45", "65862-009-50", "65862-009-60", "65862-009-90", "65862-009-01", "65862-009-33", "65862-009-05", "65862-009-99", "65862-009-44", "65862-010-50", "65862-010-60", "65862-010-90", "65862-010-01", "65862-010-33", "65862-010-05", "65862-010-99", "65862-010-46"], "is_original_packager": [true], "upc": ["0365862010018", "0365862009012", "0365862008015"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "79119", "recalling_firm": "Aurobindo Pharma Ltd.", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-0427-2018", "product_description": "Metformin Hydrochloride Tablets, USP 1000 mg, 500-count bottles, Rx Only,   Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit -VII (SEZ)) Mahabubnagar (Dt)_509302 India, NDC 65862-010-05.", "product_quantity": "7476 bottles", "reason_for_recall": "Presence of Foreign Tablet: Metformin BP 1000mg was found in bottle of Metformin HCl 1000mg", "recall_initiation_date": "20180202", "center_classification_date": "20180216", "termination_date": "20210218", "report_date": "20180228", "code_info": "Lot#: MTSC17145-A, Exp. July 2021"}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090866"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5807", "0378-5813", "0378-5814", "0378-5815"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["a5384d58-48c7-494a-a8a8-c296b316bd91"], "spl_set_id": ["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"], "package_ndc": ["0378-5807-93", "0378-5813-77", "0378-5814-77", "0378-5815-77"], "is_original_packager": [true], "upc": ["0303785815778", "0303785813774", "0303785807933", "0303785814771"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0325-2019", "product_description": "Valsartan Tablets, USP 80 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5813-77.", "product_quantity": "119,761 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot Numbers: 3065445, 3074880, 3074883, 3086688, 3086689, 3086710"}, {"status": "Terminated", "city": "Santa Clarita", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80184", "recalling_firm": "Shadow Holdings DBA Bocchi Labs", "address_1": "26421 Ruether Ave", "address_2": "N/A", "postal_code": "91350-2621", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0858-2018", "product_description": "X-Jow (menthol USP) Pain Gel, 1.25%, packaged in a) 4 oz. (113g) bottles (UPC 850547 00502 6) and b) 8 oz. (226g) bottles (UPC 8 50547 00503 3, Distributed by Herb-X Solutions, Inc., 3838 West Burbank Blvd., Burbank CA 91505.", "product_quantity": "12,252 bottles", "reason_for_recall": "CGMP Deviations: products may be contaminated with bacteria.", "recall_initiation_date": "20180525", "center_classification_date": "20180612", "termination_date": "20190813", "report_date": "20180620", "code_info": "All lots"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0167-2018", "product_description": "Benzo/Lido/Tetracaine 20%-8%-8% Topical Cream packaged in jars, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "3,280 jars", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lots: 06072017@38 BUD: 12/4/2017; 07062017@48 BUD: 1/2/2018; 08012017@23 BUD: 1/28/2018; 08212017@36 BUD: 2/17/2018; 09182017@26 BUD: 3/17/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0754-2018", "product_description": "Azithromycin 250 mg tablet #18 TEV NDC 50111-0787-66 28 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0284-2018", "product_description": "Medline Suture Removal Tray, Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "1,133 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDR1109; Lots: 17NB0789; 17EB4269  Pack Number: DYNDR1109H; Lots 17EB4269", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0451-2018", "product_description": "Ephedrine Sulfate Injection in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80923", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1184-2018", "product_description": "Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Vial, Rx only, Sterile, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 USA.  NDC:  0409-1140-01", "product_quantity": "1,580 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time point", "recall_initiation_date": "20180828", "center_classification_date": "20180907", "termination_date": "20200626", "report_date": "20180919", "code_info": "Lot: DP602, 10/2018"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0184-2018", "product_description": "Methylene Blue (PF) 10 mg/mL (1%) Injectable Vial, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "696 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 09252017@7 BUD: 12/24/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0758-2018", "product_description": "Xolair 150 mg SDV NDC 50242-0040-62 28 days", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"country": "United States", "city": "Fort Worth", "address_1": "4201 Diplomacy Rd", "reason_for_recall": "Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.", "address_2": "", "product_quantity": "5363 tubes", "code_info": "Lot #: 131965, Exp 12/2018; 127426 Exp. 01/2019; 129045, 130424 Exp. 06/2019; 130432 Exp. 10/2019; 131870 Exp. 06/2019; 132648, Exp. 03/2020; 133732 Exp. 04/2020; 134400 Exp. 02/2020; 135345 Exp. 08/2020", "center_classification_date": "20181220", "distribution_pattern": "United States, Maldives, Canada, United Arab Emirates, and New Zealand", "state": "TX", "product_description": "Advanced Protection Sunscreen spf 30 (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 Oz/127.5 g tube.", "report_date": "20181226", "classification": "Class III", "openfda": {}, "recalling_firm": "CBI Laboratories, Inc.", "recall_number": "D-0341-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81775", "termination_date": "20200114", "more_code_info": "", "recall_initiation_date": "20181210", "postal_code": "76155-2633", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0196-2019", "product_description": "Trimix 30-1-30 Papavarin 30 mg/Phentolamine 1 mg/Alprostadil 30 mg/mL Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1319-10", "product_quantity": "50 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 06192018:98 Discard by: 12/16/2018"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81311", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0095-2019", "product_description": "Meropenem for Injection, USA (I.V.), 1 gram/vial, 25 vials per carton, Sterile, Rx Only, Manufactured for: Hospira, Inc., Lake Forest, IL 60045, USA.  NDC carton: 0409-3506-01; NDC vial: 0409-3506-11", "product_quantity": "71,075 vials", "reason_for_recall": "Lack of assurance of sterility: loss of container integrity.", "recall_initiation_date": "20180920", "center_classification_date": "20181024", "termination_date": "20220917", "report_date": "20181031", "code_info": "Lot: 609G047, EXP 10/2018"}, {"country": "United States", "city": "Olive Branch", "address_1": "1 & 2", "reason_for_recall": "Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.", "address_2": "154 Downing Street", "product_quantity": "Unknown", "code_info": "Lot #: 15817VP-01, 15817VP-02, 15817VP-03, Exp 9/30/2019; 15818001, Exp 3/31/2020.", "center_classification_date": "20180907", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "state": "MS", "product_description": "Levothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-158-04.", "report_date": "20180829", "classification": "Class I", "openfda": {}, "recalling_firm": "Westminster Pharmaceuticals LLC", "recall_number": "D-1182-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80719", "termination_date": "20200603", "more_code_info": "", "recall_initiation_date": "20180803", "postal_code": "38654", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0516-2018", "product_description": "Phentolamine Mesylate USP for prescription compounding, packaged in a) 1g (NDC 58597-8077-3); b) 5g (NDC 58597-8077-4); c) 500g (NDC 58597-8077-7), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "6000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 080315-1, Exp. 04/05/2018; b) 080315-1, Exp. 04/05/2018, c) 080315-1, Exp. 04/05/2018."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0214-2019", "product_description": "Testosterone Cypionate/Proprinate 200 mg/10 mg/1 mL 30 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1745-30", "product_quantity": "580 vials and 30000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 02272018:63/A Discard by: 2/22/2019; 08162018:63/A Discard by: 4/30/2019; 10092017:30 Discard by: 10/1/2018; 02272018:63 Discard by: 2/22/2019; 08162018:63 Discard by: 4/30/2019"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "2,938 cases", "code_info": "Product Code: 6308; Lots:  55134, EXP 08/28/2017, 56144, 56521, EXP 09/26/2017;  57495, EXP 11/13/2017; 58716, EXP 04/03/2018; 59486, EXP 06/15/2018; 59504, EXP 07/16/2018; 60426, EXP 08/02/2018; 61665,EXP 10/16/2018; 62033, 62058, EXP 11/12/2018.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q Care Continue Care for the non-ventilated patient. Contains, 1 Covered Yankauer, 3 Suction Toothbrush packages with Corinz Antiseptic Cleansing and Moisturizing Oral Rinse. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6308 UPC 6 18029 83040 1", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0372-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0204-2018", "product_description": "Vitamin 9 A/B Lyophilized Vial, For IM Use, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "3612 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lots: 06092017@2 BUD: 12/6/2017; 07212017@16 BUD: 1/17/2018; 07312017@26 BUD: 1/27/2018; 08182017@5 BUD: 2/14/2018; 09222017@2 BUD: 3/21/2018; 09292017@2 BUD: 3/28/2018; 10062017@2 BUD: 4/4/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Waukon", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80963", "recalling_firm": "Beaumont Bio-med, Inc.", "address_1": "21 1st Ave NE", "address_2": "N/A", "postal_code": "52172-1705", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1195-2018", "product_description": "Diarrhea Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed by Beaumont Bio-Med, Inc., Waukon, IA 52172; NDC 58066-7022-7", "product_quantity": "160 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20180831", "center_classification_date": "20180917", "termination_date": "20220916", "report_date": "20180926", "code_info": "Lot: 090915A, Exp 09/2018"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0108-2019", "product_description": "Woman Power, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879 NDC 61096-0034-1 and Tester NDC 61096-1034-1", "product_quantity": "1,284 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80045", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to physicians and internet sales throughout the United States and Hong Kong, Panama, UK, China, Jordan, Qatar, Kuwait, and Central America.", "recall_number": "D-0832-2018", "product_description": "T Shampoo For Hair and Body, Solution Coal Tar 3% (0.6% coal tar), 300 ml/10.1 fl. oz. bottles, Dermatologic Cosmetic Laboratories, East Haven, CT", "product_quantity": "952 bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20180504", "center_classification_date": "20180522", "termination_date": "20190318", "report_date": "20180530", "code_info": "Lot # MT390-8, expiration date 12/01/2020  GU925-4, expiration date 07/05/2020"}, {"status": "Terminated", "city": "Grand Island", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA088912"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-186"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807632", "1807636", "1807637", "1807638"], "spl_id": ["75c567e3-582b-4fff-9a72-f326f1d13c8f"], "spl_set_id": ["f62481fd-fcdb-4be6-ac13-29c590e925c3"], "package_ndc": ["63323-186-04", "63323-186-02", "63323-186-01", "63323-186-10", "63323-186-03", "63323-186-20"], "is_original_packager": [true], "upc": ["0363323186036"], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "81570", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3159 Staley Rd", "address_2": "N/A", "postal_code": "14072-2028", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA and Puerto RIco", "recall_number": "D-0298-2019", "product_description": "SODIUM CHLORIDE INJECTION, USP, 0.9%, 10 mL Single Dose Vial, packaged in a 25-unit tray, Rx Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173. NDC 63323-186-10 Product code 918610", "product_quantity": "23,745,300 10 mL vials", "reason_for_recall": "Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex.  The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex.  The above listed product codes and batches being recalled have stoppers containing natural rubber latex.", "recall_initiation_date": "20181115", "center_classification_date": "20181214", "termination_date": "20230501", "report_date": "20181212", "code_info": "Lot#         EXP date:  6013112 11/2018  6013113 11/2018  6013114 11/2018  6013180 11/2018  6013181 11/2018  6013182 11/2018  6013237 01/2019  6013238 01/2019  6013239 01/2019  6013468 02/2019  6013512 02/2019  6013513 02/2019  6013551 02/2019  6013552 02/2019  6013553 02/2019  6013607 02/2019  6013608 02/2019  6013610 02/2019  6013627 03/2019  6013678 03/2019  6013679 03/2019  6013822 03/2019  6013823 03/2019  6013824 03/2019  6013924 04/2019  6013925 04/2019  6013926 04/2019  6014003 05/2019  6014004 05/2019  6014005 05/2019  6014260 05/2019  6014301 05/2019  6014302 05/2019  6014303 06/2019  6014304 06/2019  6014305 06/2019  6014306 06/2019  6014307 06/2019  6014384 06/2019  6014404 06/2019  6014405 06/2019  6014453 06/2019  6014454 06/2019  6014455 06/2019  6014479 06/2019  6014557 07/2019  6014558 07/2019  6014606 07/2019  6014649 08/2019  6014650 08/2019  6014704 08/2019  6014766 08/2019  6014767 08/2019  6014768 08/2019  6014841 08/2019  6014842 08/2019  6014843 08/2019  6014861 08/2019  6014862 08/2019  6014863 08/2019  6015049 09/2019  6015050 09/2019  6015088 09/2019  6015118 10/2019  6015127 10/2019  6015128 10/2019  6015186 10/2019  6015187 10/2019  6015188 10/2019  6015233 10/2019  6015234 10/2019  6015235 10/2019  6015285 11/2019  6015286 11/2019  6015287 11/2019  6015408 11/2019  6015409 11/2019  6015410 11/2019  6015452 11/2019  6015453 11/2019  6015454 11/2019  6015572 11/2019  6015573 12/2019  6015574 12/2019  6015616 12/2019  6015617 12/2019  6015618 12/2019  6015922 01/2020  6015923 01/2020  6015924 01/2020  6016002 02/2020  6016003 02/2020  6016004 02/2020  6016077 02/2020  6016104 02/2020  6016208 02/2020  6016209 02/2020  6016210 02/2020  6016258 02/2020  6016259 02/2020  6016260 02/2020  6016261 02/2020  6016262 03/2020  6016263 03/2020  6016264 03/2020  6016323 03/2020  6016324 03/2020  6016325 03/2020  6016383 03/2020  6016384 03/2020  6016385 03/2020  6016386 03/2020  6016387 03/2020  6016388 03/2020  6016389 03/2020  6016584 04/2020  6016585 04/2020  6016621 04/2020  6016622 04/2020  6016623 04/2020  6016765 05/2020  6016766 05/2020  6016767 05/2020  6016768 05/2020  6016769 05/2020  6016875 06/2020  6016876 06/2020  6016877 06/2020  6016878 06/2020  6016879 06/2020  6017288 06/2020  6017289 06/2020  6017290 06/2020  6017291 06/2020  6017382 07/2020  6017425 07/2020  6017426 07/2020  6017427 07/2020  6017428 07/2020  6017429 07/2020  6017470 07/2020  6017471 07/2020  6017472 07/2020  6017473 07/2020  6017474 07/2020  6017675 08/2020  6017725 08/2020  6017726 08/2020  6013062 11/2018  6014162 05/2019  6014163 05/2019  6014164 05/2019  6014377 06/2019  6014378 06/2019  6014379 06/2019  6016005 02/2020  6016071 02/2020  6016072 02/2020  6016073 02/2020  6017383 07/2020  6017384 07/2020  6017422 07/2020  6017423 07/2020  6017424 07/2020    non US  6013112 11/2018  6013113 11/2018  6013114 11/2018  6013180 11/2018  6013181 11/2018  6013182 11/2018  6013237 01/2019  6013238 01/2019  6013239 01/2019  6013468 02/2019  6013512 02/2019  6013513 02/2019  6013551 02/2019  6013552 02/2019  6013553 02/2019  6013607 02/2019  6013608 02/2019  6013610 02/2019  6013627 03/2019  6013678 03/2019  6013679 03/2019  6013822 03/2019  6013823 03/2019  6013824 03/2019  6013924 04/2019  6013925 04/2019  6013926 04/2019  6014003 05/2019  6014004 05/2019  6014005 05/2019  6014260 05/2019  6014301 05/2019  6014302 05/2019  6014303 06/2019  6014304 06/2019  6014305 06/2019  6014306 06/2019  6014307 06/2019  6014384 06/2019  6014404 06/2019  6014405 06/2019  6014453 06/2019  6014454 06/2019  6014455 06/2019  6014479 06/2019  6014557 07/2019  6014558 07/2019  6014606 07/2019  6014649 08/2019  6014650 08/2019  6014704 08/2019  6014766 08/2019  6014767 08/2019  6014768 08/2019  6014841 08/2019  6014842 08/2019  6014843 08/2019  6014861 08/2019  6014862 08/2019  6014863 08/2019  6015049 09/2019  6015050 09/2019  6015088 09/2019  6016209 02/2020  6016210 02/2020  6016258 02/2020  6016259 02/2020  6016260 02/2020  6016261 02/2020  6016262 03/2020  6016263 03/2020  6016264 03/2020  6016323 03/2020  6016324 03/2020  6016325 03/2020  6016383 03/2020  6016384 03/2020  6016385 03/2020  6016386 03/2020  6016387 03/2020  6016388 03/2020  6016389 03/2020  6016584 04/2020  6016585 04/2020  6016621 04/2020  6016622 04/2020  6016623 04/2020  6016765 05/2020  6016766 05/2020  6016767 05/2020  6016768 05/2020  6016769 05/2020  6016875 06/2020  6016876 06/2020  6016877 06/2020  6016878 06/2020  6016879 06/2020  6017288 06/2020  6017289 06/2020  6017290 06/2020  6017291 06/2020  6017382 07/2020  6017425 07/2020  6017426 07/2020  6017427 07/2020  6017428 07/2020  6017429 07/2020  6017470 07/2020  6017471 07/2020  6017472 07/2020  6017473 07/2020  6017474 07/2020  6017675 08/2020  6017726 08/2020"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80118", "recalling_firm": "Guardian Pharmacy Services", "address_1": "7920 Elmbrook Dr Ste 108", "address_2": "N/A", "postal_code": "75247-4933", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-1068-2018", "product_description": "Glutathione 200 mg/mL 100 ml. Rx Only. Packaged in 50ml MDV vials. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247", "product_quantity": "100 50-ml vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20180517", "center_classification_date": "20180808", "termination_date": "20201125", "report_date": "20180815", "code_info": "Lot: 58653:42 Use By: 06/12/2018; 58773/58766 Use By: 06/21/2018; 58766:42 Use By: 06/20/2018;"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077073"], "brand_name": ["AMLODIPINE BESYLATE"], "generic_name": ["AMLODIPINE BESYLATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-126", "69097-127", "69097-128"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE"], "rxcui": ["197361", "308135", "308136"], "spl_id": ["acf4c672-f280-41fe-a57c-67df24582038"], "spl_set_id": ["5409b296-3bed-47cd-abba-9fe6f6833af6"], "package_ndc": ["69097-126-05", "69097-126-15", "69097-127-05", "69097-127-15", "69097-128-05", "69097-128-15", "3690971281"], "is_original_packager": [true], "upc": ["0369097128050", "0369097126056", "0369097127053", "369097128159"], "unii": ["864V2Q084H"]}, "product_type": "Drugs", "event_id": "81099", "recalling_firm": "InvaGen Pharmaceuticals, Inc.", "address_1": "7 Oser Ave", "address_2": "", "postal_code": "11788-3811", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide with the United States", "recall_number": "D-0012-2019", "product_description": "Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise FL 33323  UPC 369097128159, NDC 69097-128-15", "product_quantity": "2880 bottles", "reason_for_recall": "Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month  long term stability condition.", "recall_initiation_date": "20181003", "center_classification_date": "20181011", "termination_date": "20210713", "report_date": "20181017", "code_info": "Lot #: GG80218, Exp. 12/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81638", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two medical facilities in Pennsylvania.", "recall_number": "D-0284-2019", "product_description": "Nitrofurantoin Monohydrate/Macrocrystals capsules,100 mg, packaged in HDPE 60 cc bottles, Rx only, MFG: Sandoz Inc., Princeton, NJ, Repackaged by: RemedyRepack, Indiana, PA, Original NDC 00185-0122-01Repackaged NDC 70518-1087-00, 14 capsules in HDPE 60 cc bottles in cardboard trays & HDPE 60 cc bottles in plastic bags, Repackaged NDC 70518-1087-01, 10 capsules in HDPE 60 cc bottles in cardboard trays.", "product_quantity": "3,148 capsules", "reason_for_recall": "Cross contamination with other products: Product is being recalled due to the potential presence of unrelated ingredients (Benazepril, Haloperidol and Perphenazine).", "recall_initiation_date": "20181107", "center_classification_date": "20181127", "termination_date": "20190401", "report_date": "20181205", "code_info": "Lot #: B0484872-081718, B0481339-081018, Exp 08/2019; B0506246-092718, Exp 09/2019; B0509938-100418, Exp 10/2019"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80557", "recalling_firm": "MAJOR PHARMACEUTICALS", "address_1": "17177 N Laurel Park Dr", "address_2": "N/A", "postal_code": "48152-2693", "voluntary_mandated": "N/A", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide.", "recall_number": "D-0966-2018", "product_description": "Unit Dose Valsartan Tablets, USP, 80 mg. Rx only, Distributed by:  Major Pharmaceuticals, Livonia, MI 48152, NDC# 0904-6594-61.", "product_quantity": "5,464 cartons", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180718", "center_classification_date": "20180720", "termination_date": "20221002", "report_date": "20180801", "code_info": "Major Label Unit Dose 10 x 10 Cartons 80 mg Item # 302086. Lot# T-01270 (Expiry: 7/18). Lot# T-01466 (Expiry: 7/18). Lot# T-01500 (Expiry:2/19). Lot# T-01596 (Expiry: 2/19). Lot# T-01625 (Expiry: 2/19). Lot# T-01712 (Expiry: 2/19). Lot# T-01795 (5/19). Lot# T-01807 (Expiry: 5/19)."}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80940", "recalling_firm": "Avkare Incorporated", "address_1": "114 S 1st St", "address_2": "N/A", "postal_code": "38478-3216", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1176-2018", "product_description": "AvKARE Valsartan and Hydrochlorothiazide 320 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478,  NDC 42291-886-90", "product_quantity": "12950 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180718", "center_classification_date": "20180906", "termination_date": "20200507", "report_date": "20180912", "code_info": "Lots: 17780 Exp. 09/2018; 18029 Exp. 09/2018; 18398 Exp. 09/2018; 18723 Exp. 09/2018; 19017 Exp. 02/2019; 19224 Exp. 02/2019; 20032 Exp. 08/2019; 20289 Exp. 08/2019; 21076 Exp. 08/2019; 21382 Exp. 08/2019"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0517-2018", "product_description": "Prilocaine HCl USP for prescription compounding, packaged in a) 100g (NDC 58597-8028-6); b)  500g (NDC 58597-8028-7); c) 1000g (NDC 58597-8028-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "20700 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 071117-1, Exp. 06/16/2020; b) 071117-1, Exp. 06/16/2020; c) 071117-1, Exp. 06/16/2020"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204821"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Solco Healthcare US, LLC"], "product_ndc": ["43547-367", "43547-368", "43547-369", "43547-370"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["c540c941-b8fc-4a32-bfa7-00fba4ca9dcf"], "spl_set_id": ["26080940-bcd3-446d-9026-3ddfb58e281e"], "package_ndc": ["43547-367-03", "43547-367-09", "43547-367-50", "43547-367-11", "43547-368-03", "43547-368-09", "43547-368-50", "43547-368-11", "43547-369-03", "43547-369-09", "43547-369-50", "43547-369-11", "43547-370-03", "43547-370-09", "43547-370-50", "43547-370-11"], "is_original_packager": [true], "upc": ["0343547370039", "0343547369033", "0343547368036", "0343547367039"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "78651", "recalling_firm": "Prinston Pharmaceutical Inc", "address_1": "2002 Eastpark Blvd", "address_2": "N/A", "postal_code": "08512-3514", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0209-2018", "product_description": "Valsartan Tablets, USP, 160 mg, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare US, LLC, Cranbury, NJ 08512, USA; NDC 43547-369-09.", "product_quantity": "21,987 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.", "recall_initiation_date": "20171129", "center_classification_date": "20180108", "termination_date": "20190816", "report_date": "20180117", "code_info": "Lot #: 343B17025, Exp 03/31/19", "more_code_info": ""}, {"status": "Terminated", "city": "Paramount", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78841", "recalling_firm": "DLC Laboratories, Inc", "address_1": "7008 Marcelle St", "address_2": "N/A", "postal_code": "90723-4839", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0241-2018", "product_description": "Earth's Care Eczema Lotion (2% Colloidal Oatmeal) Skin Protectant with Aloe and Almond Oil, 8 fl. oz. (237 mL) HPDE bottle, Distributed by: Earth's Care Natural Products, Inc. Long Beach, California 90805, NDC 24286-1569-08, UPC 85730700307.", "product_quantity": "4,081 HDPE bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products.", "recall_initiation_date": "20171228", "center_classification_date": "20180125", "termination_date": "20191218", "report_date": "20180131", "code_info": "Batch # 4317; Exp. 02/19  Batch # 4393; Exp. 05/19  Batch # 4437; Exp. 07/19"}, {"country": "United States", "city": "Lakewood", "address_1": "1200 Paco Way", "reason_for_recall": "Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability", "address_2": "", "product_quantity": "1277 bags", "code_info": "Lot A060644, May 2018", "center_classification_date": "20180323", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10", "report_date": "20180404", "classification": "Class III", "openfda": {}, "recalling_firm": "Renaissance Lakewood, LLC", "recall_number": "D-0605-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79310", "termination_date": "20200410", "more_code_info": "", "recall_initiation_date": "20180302", "postal_code": "08701-5938", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090483"], "brand_name": ["AMLODIPINE AND VALSARTAN"], "generic_name": ["AMLODIPINE AND VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1721", "0378-1722", "0378-1723", "0378-1724"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "VALSARTAN"], "rxcui": ["722126", "722131", "722134", "722137"], "spl_id": ["97bfe7c1-7e4b-45a1-b045-ff48275f1488"], "spl_set_id": ["aa7e7d95-520a-461c-b1b3-e588aeb6a613"], "package_ndc": ["0378-1721-93", "0378-1722-93", "0378-1723-93", "0378-1724-93"], "is_original_packager": [true], "upc": ["0303781722933", "0303781723930", "0303781721936", "0303781724937"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["864V2Q084H", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81613", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0318-2019", "product_description": "Amlodipine and Valsartan Tablets, USP, 10 mg/320 mg, 30-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-1724-93.", "product_quantity": "48,302 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.", "recall_initiation_date": "20181120", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot # 3061986, exp. date 11/2018   Lot # 3079709, exp. date 1/2020   Lot # 3077618, exp. date 11/2019   Lot # 3079708, exp. date 1/2020"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018016"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0043", "0338-0049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807627", "1807630", "1807631", "1807632", "1807633", "1807634", "1807639"], "spl_id": ["6ab23768-efd2-4ff1-b336-0dda08dc56e1"], "spl_set_id": ["f55bd888-5e01-474d-871b-24654c070178"], "package_ndc": ["0338-0049-01", "0338-0049-02", "0338-0049-03", "0338-0049-04", "0338-0049-10", "0338-0049-41", "0338-0049-11", "0338-0049-31", "0338-0049-48", "0338-0049-18", "0338-0049-38", "0338-0043-03", "0338-0043-04"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "80881", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX and MS only", "recall_number": "D-1128-2018", "product_description": "0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 0338-0049-18", "product_quantity": "33600 bags", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20180821", "center_classification_date": "20180827", "termination_date": "20191030", "report_date": "20180905", "code_info": "Lot #: P380287, Exp. date 12/2019"}, {"status": "Terminated", "city": "Farmingdale", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090796"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["TIME CAP LABORATORIES, INC"], "product_ndc": ["49483-602", "49483-603", "49483-604"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197805", "197806", "197807"], "spl_id": ["27b8b074-c62d-7214-e063-6294a90adb69"], "spl_set_id": ["ec3e8443-d742-4c25-8516-f0df4ebfccdc"], "package_ndc": ["49483-602-01", "49483-602-50", "49483-603-03", "49483-603-50", "49483-603-05", "49483-603-01", "49483-604-01", "49483-604-50", "49483-604-05", "49483-604-03"], "is_original_packager": [true], "upc": ["0349483604504", "0349483604016", "0349483602012", "0349483602500", "0349483603507", "0349483603019"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "79349", "recalling_firm": "Time-Cap Laboratories, Inc.", "address_1": "7 Michael Ave", "address_2": "N/A", "postal_code": "11735-3921", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0687-2018", "product_description": "Ibuprofen Tablets USP 400 mg, a) 100 tablet (NDC 49483-602-01) and b) 500 tablet (NDC 49483-602-50) bottles, Rx, Manufactured for: Time Cap labs, Inc., Farmingdale, NY 11735, USA, Manufactured by: Marksans Pharma, Ltd., Plot No. L-82, L-83 Verna indl. Estate Verna, Goa-403 722, India", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.", "recall_initiation_date": "20180111", "center_classification_date": "20180422", "termination_date": "20210120", "report_date": "20180502", "code_info": "a) M104C, exp 9/18, L016C, H092C, and H093C, exp 9/18    b) C128C, C129C, C130C, C132C, exp 3/18, HK6011, exp 7/18, L016C and H092C, exp 9/18,"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0316-2018", "product_description": "Medline Abdominal Surgery II Pack-LF, Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Northfield, IL 60093", "product_quantity": "144 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: PHS541637005", "more_code_info": ""}, {"status": "Terminated", "city": "Mcpherson", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075240"], "brand_name": ["LABETALOL HYDROCHLORIDE"], "generic_name": ["LABETALOL HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-0125", "0409-2267"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LABETALOL HYDROCHLORIDE"], "rxcui": ["896771"], "spl_id": ["54801b0d-200b-4df2-92f0-b5b787c4fb8b"], "spl_set_id": ["abfc6b75-1ed5-41f1-0484-4597488237bc"], "package_ndc": ["0409-2267-20", "0409-2267-54", "0409-0125-01", "0409-0125-25", "0409-2267-25"], "is_original_packager": [true], "unii": ["1GEV3BAW9J"]}, "product_type": "Drugs", "event_id": "79238", "recalling_firm": "Hospira Inc. A Pfizer Company", "address_1": "1776 Centennial Dr", "address_2": "N/A", "postal_code": "67460-9301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0576-2018", "product_description": "Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a) Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-20; and b) NOVAPLUS, Manufactured by Hospira, Inc., Lake Forest, IL  60045, NDC 0409-2267-25.", "product_quantity": "a) 137,975 vials; b) 40,143 vials", "reason_for_recall": "Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.", "recall_initiation_date": "20180220", "center_classification_date": "20180302", "termination_date": "20200402", "report_date": "20180314", "code_info": "Lots: a) 74370DD, Exp 1FEB2019; 75035DD, 75115DD, Exp 1MAR2019; b) 74230DD, Exp 1FEB2019"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206906"], "brand_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "generic_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-854", "65862-855", "65862-856", "65862-857"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "OLMESARTAN MEDOXOMIL"], "rxcui": ["730861", "730866", "730869", "730872"], "spl_id": ["4879a01c-0ba7-4d27-9847-f22e8546fa8f"], "spl_set_id": ["b13a8b46-104e-4b75-8f4a-928d2204eff5"], "package_ndc": ["65862-854-30", "65862-855-30", "65862-856-30", "65862-857-30"], "is_original_packager": [true], "upc": ["0365862855305", "0365862856302", "0365862854308", "0365862857309"], "unii": ["6M97XTV3HD", "864V2Q084H"]}, "product_type": "Drugs", "event_id": "81703", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0289-2019", "product_description": "Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, Rx only, 30-count bottle, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 0852 Made in India, NDC 65862-855-30", "product_quantity": "4464 bottles", "reason_for_recall": "Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from this lot were a pink color instead of cream (peach).", "recall_initiation_date": "20181130", "center_classification_date": "20181206", "termination_date": "20220201", "report_date": "20181212", "code_info": "Lot#: OWSA18002-A, Exp 7/2020"}, {"status": "Terminated", "city": "Hyderabad", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA205064"], "brand_name": ["ARIPIPRAZOLE"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-819", "31722-820", "31722-827", "31722-828", "31722-829", "31722-830"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "rxcui": ["349490", "349545", "349547", "349553", "402131", "602964"], "spl_id": ["10628de5-d649-12ef-e063-6394a90ae380"], "spl_set_id": ["2d8d574b-fbf4-4d2c-a37c-25556ecbf1aa"], "package_ndc": ["31722-820-30", "31722-820-01", "31722-820-31", "31722-820-32", "31722-820-05", "31722-827-30", "31722-827-01", "31722-827-31", "31722-827-32", "31722-827-05", "31722-819-30", "31722-819-01", "31722-819-31", "31722-819-32", "31722-819-05", "31722-828-30", "31722-828-01", "31722-828-31", "31722-828-32", "31722-828-05", "31722-829-30", "31722-829-01", "31722-829-31", "31722-829-32", "31722-829-05", "31722-830-30", "31722-830-01", "31722-830-31", "31722-830-32", "31722-830-05"], "is_original_packager": [true], "upc": ["0331722828055", "0331722820301"], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"]}, "product_type": "Drugs", "event_id": "78809", "recalling_firm": "Hetero Labs, Ltd. - Unit III", "address_1": "Plot 22-110, Part Ii, Ida", "address_2": "Rangareddy, Jeedimetla", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ Only", "recall_number": "D-0594-2018", "product_description": "Aripiprazole Tablets, USP, 10 mg, 30-count bottles,  Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By; Hetero Hetero Labs Limited Unit V Polepallly Jadcheria Mahaboob Nagar - 509 301 India, NDC 31722-827-30", "product_quantity": "3000  bottles", "reason_for_recall": "CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.", "recall_initiation_date": "20180110", "center_classification_date": "20180313", "termination_date": "20200921", "report_date": "20180214", "code_info": "Lot #: ARI17089, ARI17090, Exp. 5/2019"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0441-2018", "product_description": "Ketamine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Donna", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "78720", "recalling_firm": "BotanicalNow", "address_1": "17260 Dillon Rd", "address_2": "N/A", "postal_code": "78537-5199", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0471-2018", "product_description": "BodySlim Herbal Advanced technology & Strong formula capsules, 400 mg, 30-count bottle, Barcode: 9567153432481", "product_quantity": "5 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: FDA analysis found the product to contain undeclared sibutramine.", "recall_initiation_date": "20171207", "center_classification_date": "20180220", "termination_date": "20200925", "report_date": "20180131", "code_info": "MFD: 05.06.2016 EXP: 05.05.2018"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "2424 Cases", "code_info": "Product Code: 6592; Lots: 54071, EXP 10/31/2017; 54664, EXP 12/31/2017; 55007, EXP 11/30/2017; 55866, EXP 12/31/2017; 56487, 56516, 57057, EXP 02/28/2018; 58756, 58766, EXP 06/30/2018; 59618, EXP 07/31/2018; 60036, 60346, EXP 08/31/2019.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Oral Cleansing & Suctioning System q2 with 0.12% Chlorexidine Gluconate (CHG) Oral Rinse. Contains 1 Covered Yankauer and Y-Connector, 2 Untreated Suction Toothbrush packages, 2 Single dose bottles of 0.12% CHG Oral Rinse,  packages   SYS W/CHG 10, Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6592", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0385-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Niles", "address_1": "7711 N Merrimac Ave", "reason_for_recall": "Subpotent Drug: The product has failed to maintain its label claim of coal tar throughout its labeled 24-month expiry period.", "address_2": "", "product_quantity": "206,513 tubes", "code_info": "Lot #:  61031, 61041, 61051, Exp. 4/30/2018; 61601, 61651, 61751,  Exp. 6/30/2018; 61941, Exp. 7/31/2018; 62321, Exp. 8/31/2018; 62561, 62721, Exp. 9/30/2018; 62871, Exp. 10/31/2018; 63331,  Exp. 11/30/2018; 72011, 72021, 72131, 72141, Exp. 7/31/2019; 72221, 72441, Exp. 8/31/2019; 72921, Exp. 10/31/2019; 73351, Exp. 11/30/2019", "center_classification_date": "20180312", "distribution_pattern": "Nationwide in the USA; Italy; Sweden; Germany; New Zealand; Netherlands; Australia; Moldova; United Kingdom; Mexico; Brazil; Chile; Greece; Spain; Norway; Belgium; Bulgaria", "state": "IL", "product_description": "Psoriasin Daytime Relief Cream with Vitamin D & Oatmeal, (Coal Tar 1.25%), packagedin 57 g plastic tubes, Distributed by: ALVA-AMCO Pharmacal Cos., Inc., Niles, IL 60714, USA.   NDC 52389-745-56, UPC 0 72959 01045 4.", "report_date": "20180321", "classification": "Class III", "openfda": {}, "recalling_firm": "Alva-Amco Pharmacal Companies., Inc.", "recall_number": "D-0589-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79450", "termination_date": "20200626", "more_code_info": "", "recall_initiation_date": "20180309", "postal_code": "60714-3423", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "200 bags", "code_info": "Lot # 5/23/18 3812 89325P, BUD 8/6/2018.", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "PHENYLephrine 40 mg (PHENYLephrine HCL (USP) 40 mg, 5%Dextrose Inj., USP 250 mL) Volume: 254 mL. Single dose bag. Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-893-25", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0940-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lakewood", "address_1": "1200 Paco Way", "reason_for_recall": "Labeling: Label mix-up - A complaint was received of one bag of Fluconazole Injection, Iso-Osmotic Sodium Chloride Diluent, USP, 2mg/mL, 50 mL found within the package of 100 mL bags.", "address_2": "", "product_quantity": "1784 bags", "code_info": "Lot #: A0A0539, Exp. 05/19", "center_classification_date": "20180424", "distribution_pattern": "Product was distributed throughout the United States.", "state": "NJ", "product_description": "Fluconazole Injection, USP, Iso-Osmotic Sodium Chloride Diluent, 200 mg in 100 mL (2 mg/mL), package in 100 mL bags, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902, By: Claris Injectables Limited, Sarkhei-Bavla Road, Chacharwadi-Vasna, Ahmedabad, India  382213, NDC 36000-002-10", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Renaissance Lakewood, LLC", "recall_number": "D-0696-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79580", "termination_date": "20190814", "more_code_info": "", "recall_initiation_date": "20180221", "postal_code": "08701-5938", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Hurst", "address_1": "122 Grapevine Hwy", "reason_for_recall": "Labeling Not Elsewhere Classified: Misbranding.", "address_2": "", "product_quantity": "8240 capsules", "code_info": "Lots: 04052018@16 Exp. 9/11/2018; 04242018@2 Exp. 10/21/2018; 05072018@8 Exp. 10/21/2018; 05302018@3 Exp. 10/22/2018; 06192018@9 Exp. 10/22/2018; 06192018@10 Exp. 12/15/2018; 06202018@12 Exp. 12/15/2018; 07022018@15 Exp. 12/15/2018; 07242018@2 Exp. 1/13/2018; 08312018@3 Exp. 2/6/2018", "center_classification_date": "20181114", "distribution_pattern": "Distributed in California", "state": "TX", "product_description": "Progesterone SR 200 mg Capsules, packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd's Prescription Shop 122 Grapevine Hwy. Hurst, TX 76054 817-282-9376. NDC 99999-0018-74", "report_date": "20181121", "classification": "Class III", "openfda": {}, "recalling_firm": "Right Value Drug Stores, Inc.", "recall_number": "D-0241-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81198", "termination_date": "20201013", "more_code_info": "", "recall_initiation_date": "20180925", "postal_code": "76054-2406", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0295-2018", "product_description": "Medline General Purpose Instrument Set, Sterile, Single Use Only. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "3,300 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDS1014; Lots 17GB3416; 176B2045", "more_code_info": ""}, {"status": "Terminated", "city": "Weeki Wachee", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79803", "recalling_firm": "Premier Pharmacy Labs Inc", "address_1": "8265 Commercial Way", "address_2": "N/A", "postal_code": "34613-4511", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0699-2018", "product_description": "Morphine Sulfate 2 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265  Commerical Way Weeki Wachee, FL 34613. NDC 69623-129-10", "product_quantity": "4555 syringes", "reason_for_recall": "Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.", "recall_initiation_date": "20180411", "center_classification_date": "20180426", "termination_date": "20200915", "report_date": "20180502", "code_info": "Lots: MOR030518IJDSA, MOR030518IJDSB, MOR030518IJDSC, MOR030518IJDSD, MOR030518IJDSE BUD: 06/03/2018;"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0761-2018", "product_description": "Boost VHC Oral Liquid VAN #27 NDC 43900-0182-15 27 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["POVIDONE-IODINE"], "generic_name": ["POVIDONE-IODINE"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-938"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["POVIDONE-IODINE"], "rxcui": ["211747"], "spl_id": ["41c65656-ff98-67e5-e063-6394a90a6079"], "spl_set_id": ["2b95078e-2caf-7005-e054-00144ff88e88"], "package_ndc": ["53329-938-06", "53329-938-08", "53329-938-23", "53329-938-25", "53329-938-04"], "is_original_packager": [true], "nui": ["N0000175486", "M0011640"], "pharm_class_epc": ["Antiseptic [EPC]"], "pharm_class_cs": ["Iodine [CS]"], "unii": ["85H0HZU99M"]}, "product_type": "Drugs", "event_id": "79267", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "N/A", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Curacao", "recall_number": "D-0546-2018", "product_description": "PVP Scrub Solution, Povidone Iodine, 7.5% (equivalent to 0.75% available iodine), 4 FL OZ bottle, Manufactured in USA by Medline Industries, Inc., Northfield, IL 60093; Product Number MDS093945; NDC 53329-938-04", "product_quantity": "67,104 bottles", "reason_for_recall": "Subpotent Drug: product not meeting the iodine assay level requirements through the labeled expiry.", "recall_initiation_date": "20180215", "center_classification_date": "20180226", "termination_date": "20200429", "report_date": "20180307", "code_info": "Lot #: 16EJ0023, Exp 04/18"}, {"status": "Terminated", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78991", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "N/A", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed U.S.A. nationwide.", "recall_number": "D-0326-2018", "product_description": "Tatiomax Gluatathione Whitening kits, 1400mg vials, Made in Japan", "product_quantity": "N/A", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act.", "recall_initiation_date": "20180119", "center_classification_date": "20180205", "termination_date": "20180913", "report_date": "20180214", "code_info": "all lots"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0463-2018", "product_description": "Dexamethasone Sodium Phosphate added to 0.9% Sodium Chloride in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "79635", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0612-2018", "product_description": "24-HOUR Oral Care q2 Kit with Ballard* Technology, containing 2 Toothbrush Packs with CHG Solution, Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cup (NDC 50383-720-15), Rx Only, Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701; Kit Manufactured by Halyard Health, Inc., 5405 Windward Parkway, Alpharetta, GA  30004; Distributed in the USA by Halyard Sales, LLC, Alpharetta, GA 30004, Product 97012.", "product_quantity": "48,176 unit dose cups", "reason_for_recall": "Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.", "recall_initiation_date": "20180329", "center_classification_date": "20180329", "termination_date": "20200422", "report_date": "20180404", "code_info": "Chlorhexidine Gluconate Oral Rinse lot # 350836, Exp 05/18 contained within kit lot #: 0202511399, 0202511400, 0202543553, Exp 03/18; 0202518977, 0202538282, 0202538283, 0202538284, 0202538285, 0202543552, 0202642220, 0202642224, 0202642225, Exp 04/18", "more_code_info": ""}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "1273 Cases", "code_info": "Product Code: 6994; Lots: 58092, EXP 12/11/2017; 60090, EXP 07/30/2018; 60663, EXP 09/06/2018; 61261, EXP 09/11/2018; 61947, EXP 11/12/2018", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q Care Oral Cleansing & Suctioning System compatible with 0.12% Chlorhexidine Gluconate (CHG) Oral Rinse. Contains 1 Covered Yankauer and Y-Connector, 2 Untreated Suction Toothbrush packages,  4  Suction Oral Swab packages with Corinz Antiseptic Cleansing and Moisturizing Oral Rinse, 2 Oropharyngeal Suction Catheter packages. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6994 UPC 6 18029 83094 4", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0408-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80538", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States, including Hawaii and Puerto Rico", "recall_number": "D-0982-2018", "product_description": "Valsartan and Hydrochlorothiazide (HCTZ) Tablets, USP 160 mg/12.5 mg tablets, USP 90-count bottle, Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054. NDC 0591-2316-19.", "product_quantity": "195,234 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180716", "center_classification_date": "20180724", "report_date": "20180801", "code_info": "Lot Numbers:  1191160M, 1191161M, 1191162A, 1219363M, 1219364M, 1219365A, 1225613A, 1233944M, 1233945M, 1253253M, 1253254M"}, {"country": "United States", "city": "San Diego", "address_1": "3978 Sorrento Valley Blvd Ste 300", "reason_for_recall": "Lack of Processing Controls: products produced in a manner that calls into question the sterility of the drug product intended to be sterile.", "address_2": "", "product_quantity": "17,610 mL total dispensed in 10 mL and 30 mL vials", "code_info": "Lot #: 140089@1, Exp 08/06/2018; 141968@6, Exp 09/03/2018; 143381@2, Exp 09/24/2018; 145265@13, Exp 10/22/2018; 146479@6, Exp 11/12/2018", "center_classification_date": "20180713", "distribution_pattern": "Product was distributed to patients via patient specific prescription only in CA.", "state": "CA", "product_description": "Methyl Folate CA+ 1mg/ml Injection w/Pres. (Benzyl Alcohol 1% in Sterile Water), 10 mL and 30 mL vials, Rx only, la VITA Compounding Pharmacy, 858.453.2500", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "La Vita Compounding Pharmacy, LLC", "recall_number": "D-0922-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80416", "termination_date": "20190118", "more_code_info": "", "recall_initiation_date": "20180625", "postal_code": "92121-1436", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: a) 20180119@4, 20171016@10, 20171106@5, 20171214@55, 20180207@5 BUD 04/14/2018; 20180212@15, BUD 03/29/2018; 20180117@26, BUD 07/16/2018.     b) 20180219@17, BUD 08/18/2018; 20180205@1, 20180102@39, 20180124@3, BUD 04/14/2018; 20180221@23, BUD 08/20/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Methylcobalamin 12.5 mg/mL, Injectable Liquid, packaged in a) 5 mL amber vial, and b) 50 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0655-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bronx", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA085025"], "brand_name": ["HYDROCORTISONE"], "generic_name": ["HYDROCORTISONE"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-004", "45802-014"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROCORTISONE"], "rxcui": ["103401", "310891"], "spl_id": ["33fc03f5-9997-4229-8832-4dd7fa3abd76"], "spl_set_id": ["7ba59aa6-b828-4048-bf86-90c90d9894a0"], "package_ndc": ["45802-004-02", "45802-004-03", "45802-014-02", "45802-014-05"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["WI4X0X7BPJ"]}, "product_type": "Drugs", "event_id": "80049", "recalling_firm": "Perrigo New York", "address_1": "1700 Bathgate Ave", "address_2": "", "postal_code": "10457-7512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide including Puerto Rico.", "recall_number": "D-0817-2018", "product_description": "Hydrocortisone Ointment, USP 2.5%, Net Wt. 20g, Rx Only, Manufactured By Perrigo, Bronx, NY 10457, Distributed by Perrigo, Allegan MI 49010, NDC 45802-014-02", "product_quantity": "571,632 tubes", "reason_for_recall": "Failed Stability Specifications", "recall_initiation_date": "20180507", "center_classification_date": "20180516", "termination_date": "20181210", "report_date": "20180523", "code_info": "Lot Numbers:  7AT0283V, exp. 11/18  7AT0284V, exp. 11/18  7AT0285V, exp. 11/18  7FT0460, exp. 05/19  7FT0461, exp. 05/19  7GT0465, exp. 06/19  7GT0466, exp. 06/19  7JT0390, exp. 08/19  7JT0392, exp. 08/19  7KT0588, exp. 09/19  7KT0589, exp. 09/19", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0161-2018", "product_description": "Anastrozole 0.5 mg Capsules, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "15,700 capsules", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lots: 03092017@21 BUD: 3/9/2018; 03292017@33 BUD: 3/24/2018; 05092017@38 BUD: 5/4/2018; 05162017@31 BUD: 5/11/2018; 05182017@25 BUD: 5/13/2018; 07032017@40  BUD: 6/28/2018; 07142017@34 BUD: 7/9/2018; 07192017@32 BUD: 7/14/2018; 08282017@25 BUD: 8/23/2018; 09142017@8BUD: 9/9/2018; 09212017@23 BUD: 9/16/2018; 09272017@36 BUD: 9/ 22/2018; 10162017@39 BUD: 10/11/2018; 11032017@28 BUD: 10/29/2018", "more_code_info": ""}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: 20171122@65, BUD 05/21/2018; 20171115@56, BUD 05/14/2018; 20171002@77, BUD 03/31/2018; 20171006@63, BUD 04/04/2018; 20171009@55, BUD 04/07/2018; 20171117@72, BUD 05/16/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Testosterone/Anastrozole 60 mg/4 mg pellets packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0672-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hallandale Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80699", "recalling_firm": "Pharmcore Inc.", "address_1": "1109 E Hallandale Beach Blvd", "address_2": "N/A", "postal_code": "33009-4431", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1152-2018", "product_description": "Human Chorionic Gonadotropin 6000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009", "product_quantity": "3351 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20180802", "center_classification_date": "20180828", "termination_date": "20220118", "report_date": "20180905", "code_info": "Lots: HCG60122 Exp. 4/30/2019; HCG60124 Exp. 6/30/2019; HCG60121 Exp. 4/30/2019; HCG60123 Exp. 5/31/2019; HCG60120 Exp. 4/30/2019; HCG60118 Exp. 2/28/2019; HCG1115 Exp. 1/31/2019"}, {"status": "Terminated", "city": "LAKE FOREST", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80213", "recalling_firm": "ICU Medical Inc", "address_1": "600 N FIELD DRIVE", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Canada", "recall_number": "D-0882-2018", "product_description": "0.9% Sodium Chloride Injection, USP, 250 mL bag, Rx Only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-7983-02", "product_quantity": "941496 bags", "reason_for_recall": "Lack of assurance of sterility: Bags have potential to leak.", "recall_initiation_date": "20180531", "center_classification_date": "20180620", "termination_date": "20200604", "report_date": "20180627", "code_info": "Lot #: 85-018-JT, 85-031-JT, Exp. 01/01/2020"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0429-2018", "product_description": "Bupivacaine HCl in 0.9% Sodium Chloride in all doses, all strengths, and packaging.", "product_quantity": "297 bags", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0080-2019", "product_description": "Family Dollar Saline Nasal Spray 4.25 oz. can, 24 pk, SKU 0900562.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Central Islip", "address_1": "550 S Research Pl", "reason_for_recall": "Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol", "address_2": "", "product_quantity": "45,875 bottles", "code_info": "Lot Numbers: 17080591 and 17080619,  exp 07/19; 17110907 and 17110908, exp 10/19; and 17120986, exp 11/19", "center_classification_date": "20180201", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY --- NDC 31722-917-01", "report_date": "20180207", "classification": "Class III", "openfda": {"application_number": ["ANDA207418"], "brand_name": ["OXYCODONE HYDROCHLORIDE"], "generic_name": ["OXYCODONE HYDROCHLORIDE"], "manufacturer_name": ["Camber Pharmaceuticals Inc"], "product_ndc": ["31722-917", "31722-918"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OXYCODONE HYDROCHLORIDE"], "rxcui": ["1049611", "1049618"], "spl_id": ["89fb5e4f-0b68-42f8-a91f-8f07cbaec4b6"], "spl_set_id": ["01db4606-d49c-4b10-a78a-1cf41880a9fb"], "package_ndc": ["31722-917-01", "31722-917-05", "31722-918-01", "31722-918-05"], "is_original_packager": [true], "upc": ["0331722917018", "0331722918015"], "unii": ["C1ENJ2TE6C"]}, "recalling_firm": "Ascent Pharmaceuticals, Inc.", "recall_number": "D-0248-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "78990", "termination_date": "20180423", "more_code_info": "", "recall_initiation_date": "20180122", "postal_code": "11722-4415", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0502-2018", "product_description": "Levetiracetam USP for prescription compounding, packaged in a) 500g (NDC 58597-8353-7); b) 1000g (NDC 58597-8353-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "36100 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 072616-1, Exp. 06/29/2019; b) 060115-1, Exp. 01/23/2018; 072616-1, Exp. 06/29/2019;"}, {"country": "United States", "city": "Olive Branch", "address_1": "1 & 2", "reason_for_recall": "Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.", "address_2": "154 Downing Street", "product_quantity": "Unknown", "code_info": "Lot #: 15717VP-01, 15717VP-02, 15717VP-03, Exp 7/31/2019; 15717002, Exp 12/31/2019; 15718004, Exp 3/31/2020.", "center_classification_date": "20180907", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "state": "MS", "product_description": "Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 & 1/2 grain (90 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-157-04.", "report_date": "20180829", "classification": "Class I", "openfda": {}, "recalling_firm": "Westminster Pharmaceuticals LLC", "recall_number": "D-1179-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80719", "termination_date": "20200603", "more_code_info": "", "recall_initiation_date": "20180803", "postal_code": "38654", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0156-2019", "product_description": "HCG Lyophilized 5000 IU Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-1707-10", "product_quantity": "2219 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04252018:33 Discard by: 10/21/2018; 05082018:39 Discard by: 11/4/2018; 06262018:00 Discard by: 12/23/2018; 07192018:13 Discard by: 1/15/2019; 08012018:46 Discard by: 1/28/2019; 08212018:69 Discard by: 11/30/2018"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091239"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["MARKSANS PHARMA LIMITED"], "product_ndc": ["25000-114", "25000-117"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["310965"], "spl_id": ["1bdc2c02-575f-4b55-ad66-47108f628d18"], "spl_set_id": ["3c8df1e5-61bc-4e70-b6b9-8973986ad589"], "package_ndc": ["25000-114-03", "25000-114-14", "25000-114-20", "25000-114-30", "25000-114-98", "25000-114-93", "25000-114-70", "25000-114-71", "25000-114-02", "25000-117-03", "25000-117-14", "25000-117-20", "25000-117-30", "25000-117-98", "25000-117-93", "25000-117-69", "25000-117-02"], "is_original_packager": [true], "upc": ["0325000114022", "0325000117146", "0325000114039", "0325000117030", "0325000117023", "0325000114145", "0325000117696", "0325000114718", "0325000114701"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "78822", "recalling_firm": "Marksans Pharma Inc.", "address_1": "Suite # 401, 4th Floor", "address_2": "Room No. 430, 150 Motor Parkway", "postal_code": "11788", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to repackaging firms in NY who then distributed Nationwide in the USA.", "recall_number": "D-0235-2018", "product_description": "Ibuprofen Tablets, USP 200 mg, 6 x 6500 Caplets (Capsule-Shaped Tablets) bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403 722, India, NDC 25000-117-30.", "product_quantity": "2,853,500 Caplets", "reason_for_recall": "CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.", "recall_initiation_date": "20180109", "center_classification_date": "20180124", "termination_date": "20200526", "report_date": "20180131", "code_info": "Lot #: HH6001, HH6002, Exp 04/18"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0266-2018", "product_description": "Medline Central Line Dressing Change Tray Kit, Sterile, Single use only. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "14,675 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYND74661; Lots: 177B1602;  17RB9139;  16WB5199;  17CB7720;  17CB5841;  167B0074;  16GB8853;  16JB0621;  17EB4904;  16TB9798;  165B0465    Pack Number: DYND74661H; Lots: 17EB4904;  17CB5841;  17CB1032;  165B0465;  16WB5199;  17RB9139;  17CB7720;  16JB0621;  16TB9798;  177B1602;", "more_code_info": ""}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202501"], "brand_name": ["CIDOFOVIR DIHYDRATE"], "generic_name": ["CIDOFOVIR DIHYDRATE"], "manufacturer_name": ["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."], "product_ndc": ["23155-216"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CIDOFOVIR"], "rxcui": ["199388"], "spl_id": ["963405a6-8cd9-4d70-9de9-2afc6eab1488"], "spl_set_id": ["44966a7e-d777-40fb-956f-d0f31f737848"], "package_ndc": ["23155-216-31", "3231552163"], "is_original_packager": [true], "upc": ["0323155216318"], "unii": ["JIL713Q00N"]}, "product_type": "Drugs", "event_id": "81276", "recalling_firm": "Heritage Pharmaceuticals, Inc.", "address_1": "1 Tower Center Blvd Ste 1700", "address_2": "N/A", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0094-2019", "product_description": "Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure Pharmaceutical Ltd Hinjawadi, Pune, India, Mfg for: Heritage Pharmaceuticals Inc. UPC 323155216388, NDC 23155-216-31", "product_quantity": "2,789 Units", "reason_for_recall": "Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle", "recall_initiation_date": "20181015", "center_classification_date": "20181024", "termination_date": "20230329", "report_date": "20181031", "code_info": "Lot #: VCIA083, Exp. JUN2020"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0486-2018", "product_description": "Doxycycline Hyclate USP for prescription compounding, packaged in a) 25g (NDC 58597-8082-4); b) 100g (NDC 58597-8082-6); c) 500g (NDC 58597-8082-7); d) 1000g (NDC 58597-8082-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "75000", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a)  082815-1, Exp. 06/04/2019; b) 082417-1, Exp. 03/04/2020; 082815-1, Exp. 06/04/2019; c) 082815-1, Exp. 06/04/2019; d) 082815-1, Exp. 06/04/2019"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0070-2019", "product_description": "Cicatricure, Scar Cream + Sunscreen SPF 30 (avobenzone 3%, octocrylene 10%, oxybenzone 6%), 0.7 oz. (19.8 g) tube, Distributed by: Genomma Lab USA Inc., Houston, TX 77027, UPC 6 50067 00018 7.", "product_quantity": "7,944 tubes", "reason_for_recall": "Subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "Lot: 163241K, Exp. October 2018"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0534-2018", "product_description": "Verapamil HCl USP for prescription compounding, packaged in a) 100g (NDC 58597-8039-6); b) 500g (NDC 58597-8039-7); c) 1000g (NDC 58597-8039-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "50000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 072216-1, Exp. 11/26/2019; b) 072216-1, Exp. 11/26/2019; c)0 72216-1, Exp. 11/26/2019;"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80703", "recalling_firm": "Northwind Pharmaceuticals LLC", "address_1": "9402 Uptown Dr Ste 1100", "address_2": "", "postal_code": "46256-1042", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Indiana", "recall_number": "D-1096-2018", "product_description": "Valsartan HCTZ, 160/12.5mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46256. NDC: 51655-950-52", "product_quantity": "43 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180718", "center_classification_date": "20180815", "termination_date": "20230325", "report_date": "20180822", "code_info": "Lot: UTB23790003, exp 02/28/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0183-2018", "product_description": "Liothyronine SR (T3) 20 mcg Capsule, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd Boca Raton, FL 33487.", "product_quantity": "970 capsules", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lots: 05022017@24 BUD: 4/27/2018; 10122017@21 BUD: 4/10/2018; 11062017@38 BUD: 5/5/2018; 08252017@28 BUD: 8/20/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0139-2019", "product_description": "Beta-complex B-1, B-6, B-3, B-12, B-5 100, 2.54 Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1611-30", "product_quantity": "6000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 06182018:55 Discard by: 12/25/2018"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0190-2018", "product_description": "QUADMIX #17, 5 mL Vial, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "122 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 05242017@27 BUD: 11/20/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0499-2018", "product_description": "Ketoconazole USP for prescription compounding, packaged in a) 25g (NDC 58597-8053-4); b) 100g (NDC 58597-8053-6); c)  500g (NDC 58597-8053-7) RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "4600 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 091115-1, Exp. 07/31/2020;  091115-2, Exp. 07/31/2020; b) 091115-1, Exp. 07/31/2020;   c) 091115-1, Exp. 07/31/2020."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202357"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-124"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255"], "spl_id": ["3ec2bef7-b820-857f-1c70-e57c2d2c6dbf"], "spl_set_id": ["6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d"], "package_ndc": ["55111-124-30", "55111-124-60", "55111-124-90", "55111-124-05", "3551111249"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"], "upc": ["355111124900"]}, "product_type": "Drugs", "event_id": "80208", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0878-2018", "product_description": "Atorvastatin Calcium Tablets, 80 mg*, 90-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-124-90  UPC 355111124900", "product_quantity": "6,397 bottles", "reason_for_recall": "Presence of Foreign Substance: A product complaint was received for a defective tablet with an embedded foreign object observed in a bottle.", "recall_initiation_date": "20180530", "center_classification_date": "20180618", "termination_date": "20201214", "report_date": "20180627", "code_info": "Lot #: T800064, Exp 12/2019"}, {"status": "Terminated", "city": "La Habra", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80890", "recalling_firm": "Auro Pharmacies, Inc.", "address_1": "520 W La Habra Blvd", "address_2": "N/A", "postal_code": "90631-5308", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in USA", "recall_number": "D-1161-2018", "product_description": "Methyl-Cobalamin injectable, 5 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631", "product_quantity": "90 vials", "reason_for_recall": "Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.", "recall_initiation_date": "20180821", "center_classification_date": "20180829", "termination_date": "20200130", "report_date": "20180905", "code_info": "Lot #: 180618/3, Exp 16-Sep-18"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0180-2018", "product_description": "Hydroxocobalamin 0.5 mg/mL For Diluent Purpose Only 10 mL Vial, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "1,009 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 10102017@9 BUD: 2/7/2018", "more_code_info": ""}, {"country": "United States", "city": "East Haven", "address_1": "20 Commerce St", "reason_for_recall": "GMP Deviations", "address_2": "", "product_quantity": "14,491 tubes", "code_info": "Lot #: KU503-6, KU393-6, Exp. 12/28/2020", "center_classification_date": "20180515", "distribution_pattern": "Within the United States and Puerto Rico", "state": "CT", "product_description": "MD Complete Clarifying Cleanser (Salicylic Acid 2.0%), 3 fl oz, (88.7mL), MD Professional LLC, Minneapolis, MN", "report_date": "20180523", "classification": "Class II", "openfda": {}, "recalling_firm": "Milbar Laboratories, Inc.", "recall_number": "D-0814-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80042", "termination_date": "20190626", "more_code_info": "", "recall_initiation_date": "20180504", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090483"], "brand_name": ["AMLODIPINE AND VALSARTAN"], "generic_name": ["AMLODIPINE AND VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1721", "0378-1722", "0378-1723", "0378-1724"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "VALSARTAN"], "rxcui": ["722126", "722131", "722134", "722137"], "spl_id": ["97bfe7c1-7e4b-45a1-b045-ff48275f1488"], "spl_set_id": ["aa7e7d95-520a-461c-b1b3-e588aeb6a613"], "package_ndc": ["0378-1721-93", "0378-1722-93", "0378-1723-93", "0378-1724-93"], "is_original_packager": [true], "upc": ["0303781722933", "0303781723930", "0303781721936", "0303781724937"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["864V2Q084H", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81613", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0311-2019", "product_description": "Amlodipine and Valsartan Tablets, USP, 5 mg/160 mg, 30-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-1721-93.", "product_quantity": "23,478 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.", "recall_initiation_date": "20181120", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot # 3066051, exp. date 3/2019"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0430-2018", "product_description": "Fentanyl Citrate and Ropivacaine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "7 vials", "code_info": "Lot #: 20180130@2, BUD 7/29/2018; 20180109@1, BUD 07/08/2018; 20180212@51, BUD 08/11/2018;, 20171212@4, BUD 06/10/2018; 20180123@6, BUD 07/22/2018; 20171204@4, BUD 06/02/2018; 20171228@15, BUD 03/28/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Testosterone Cypionate 200mg/mL, 5 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0644-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0536-2018", "product_description": "Biotin USP (Vitamin H)  for prescription compounding, packaged in a) 500mg (NDC 58597-8142-1); b) 1g (NDC 58597-8142-2); c) 5g (NDC 58597-8142-3); d ) 25g (NDC 58597-8142-4), Rx only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "7255 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 070815-2, Exp. 04/24/2018; b) 070815-2, Exp. 04/24/2018; c) 070815-2, Exp. 04/24/2018; 110416-2, Exp. 06/30/2019; d) 110416-1, Exp. 06/30/2019; 070815-1, Exp. 04/24/2018."}, {"status": "Terminated", "city": "Greenville", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA202428"], "brand_name": ["FABIOR"], "generic_name": ["TAZAROTENE"], "manufacturer_name": ["Mayne Pharma"], "product_ndc": ["51862-295"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["TAZAROTENE"], "rxcui": ["1293451", "1293456"], "spl_id": ["26751634-0475-4657-a980-9d6594a13e34"], "spl_set_id": ["ae0afed7-1d60-45fd-a08b-8db094618521"], "package_ndc": ["51862-295-50", "51862-295-10"], "is_original_packager": [true], "nui": ["N0000175607", "M0018962"], "pharm_class_epc": ["Retinoid [EPC]"], "pharm_class_cs": ["Retinoids [CS]"], "unii": ["81BDR9Y8PS"]}, "product_type": "Drugs", "event_id": "79604", "recalling_firm": "Mayne Pharma Inc", "address_1": "1240 Sugg Pkwy", "address_2": "N/A", "postal_code": "27834-9006", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0616-2018", "product_description": "Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.", "product_quantity": "3312 cans", "reason_for_recall": "Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.", "recall_initiation_date": "20180321", "center_classification_date": "20180330", "termination_date": "20200611", "report_date": "20180411", "code_info": "Lot: MBEB, Exp. 01/31/2019"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0189-2019", "product_description": "Tilarginine Acetate 50 mg/mL, 10 mL, Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1461-10", "product_quantity": "3523 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 06212018:28 Discard by: 12/11/2019; 06152018:24 Discard by: 12/12/2018"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80118", "recalling_firm": "Guardian Pharmacy Services", "address_1": "7920 Elmbrook Dr Ste 108", "address_2": "N/A", "postal_code": "75247-4933", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-1053-2018", "product_description": "Ascorbic Acid 500 mg/mL 500 mL TPN. Rx Only. Packaged in 500 ml bag. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247", "product_quantity": "5000 500-ml bags", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20180517", "center_classification_date": "20180808", "termination_date": "20201125", "report_date": "20180815", "code_info": "Lots: 58555:42, 58567:42, 58563:42, 58547:42, 58565:42, Use By: 05/25/2018"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065095"], "brand_name": ["DOXYCYCLINE HYCLATE"], "generic_name": ["DOXYCYCLINE HYCLATE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0143-2112"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE HYCLATE"], "rxcui": ["1650143"], "spl_id": ["d3f0f038-6c53-4f67-8397-c6d0ef71a60b"], "spl_set_id": ["9b52e0a7-f024-4d8a-a59e-374946e60b44"], "package_ndc": ["0143-2112-50", "0143-2112-05", "0143-2112-20"], "is_original_packager": [true], "upc": ["0301432112508"], "unii": ["19XTS3T51U"]}, "product_type": "Drugs", "event_id": "80364", "recalling_firm": "West-Ward Columbus Inc", "address_1": "1809 Wilson Rd", "address_2": "N/A", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1025-2018", "product_description": "Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-05.", "product_quantity": "29048 500-count bottles (14,524,000 tablets)", "reason_for_recall": "Failed Dissolution Specifications:", "recall_initiation_date": "20180724", "center_classification_date": "20180802", "termination_date": "20200429", "report_date": "20180808", "code_info": "Lot# 71545A, Expiry date: 07/19"}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80847", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1137-2018", "product_description": "Amlodipine and Valsartan Tablets, USP, 10 mg/320 mg, 30 tablets per bottle, Rx Only, Manufactured by:  Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-204-30", "product_quantity": "89616 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180817", "center_classification_date": "20180828", "report_date": "20180905", "code_info": "Batch: BV77D013,  BV77C011,  BV77D001,  BV77D002,  BV77D003,  BV77D004,  BV77D005,  BV77D006,  BV77D007,  BV77D008,  BV77D009 ,  BV77D010,  BV77D011,  BV77D012,  BV77C009,  BV77C010"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0174-2019", "product_description": "Prostaglandin E1 40 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1347-05", "product_quantity": "154 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04262018:95 Discard by: 10/22/2018; 03292018:59 Discard by: 9/24/2018; 05312018:66 Discard by: 11/27/2018; 06122018:07 Discard by: 12/9/2018"}]